ENGERIX-B (GlaxoSmithKline Biologicals SA)
Welcome to the PulseAid listing for the ENGERIX-B drug offered from GlaxoSmithKline Biologicals SA. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline Biologicals SA |
NON-PROPRIETARY NAME: | Hepatitis B Vaccine (Recombinant) |
SUBSTANCE NAME: | HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN |
TYPE: | VACCINE |
PHARMA CLASS: | |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION, SUSPENSION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2007-04-25 |
END MARKETING DATE: | 0000-00-00 |
ENGERIX-B VACCINE Details:
Item Description | ENGERIX-B from GlaxoSmithKline Biologicals SA |
LABELER NAME: | GlaxoSmithKline Biologicals SA |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(ug/.5mL) |
START MARKETING DATE: | 2007-04-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 58160-820_bac87f9e-8514-477a-8c92-3a5ed504ddc5 |
PRODUCT NDC: | 58160-820 |
APPLICATION NUMBER: | BLA103239 |
Other HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN Pharmaceutical Manufacturers / Labelers: